Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension

Clinical trial NCT04910100 · COMPLETED

Trial details

NCT number: NCT04910100
Sponsor: Betaliq, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Open-Angle Glaucoma Ocular Hypertension

Start date: 2021-04-15
Primary completion: 2022-03-31
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.